Ident. | Authors (with country if any) | Title |
---|
000056 (2014) |
J. J. Brugts [Pays-Bas] ; Hisatomi Arima [Australie] ; W. Remme [Pays-Bas] ; M. Bertrand [France] ; R. Ferrari [Italie] ; K. Fox [Royaume-Uni] ; J. Dinicolantonio [États-Unis] ; S. Macmahon [Australie] ; J. Chalmers [Australie] ; F. Zijlstra [Pays-Bas] ; K. Caliskan [Pays-Bas] ; M. L. Simoons [Pays-Bas] ; J. J. Mourad [France] ; E. Boersma [Pays-Bas] ; K. M. Akkerhuis [Pays-Bas] | The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease |
002158 (2010) |
Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; LISHENG LIU [République populaire de Chine] ; Christophe Tzourio [France] ; Mark Woodward [États-Unis] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Anthony Rodgers [Australie] ; John Chalmers [Australie] | Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial |
002339 (2010) |
Sébastien Czernichow [Australie, France] ; Toshiharu Ninomiya [Australie] ; Rachel Huxley [Australie] ; André-Pascal Kengne [Australie] ; G. David Batty [Australie, Royaume-Uni] ; Diederick E. Grobbee [Pays-Bas] ; Mark Woodward [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial |
002389 (2010) |
Jasper Jan Brugts [Pays-Bas] ; Aaron Isaacs [Pays-Bas] ; Eric Boersma [Pays-Bas] ; Cock M. Van Duijn [Pays-Bas] ; Andre G. Uitterlinden [Pays-Bas] ; Willem Remme [Pays-Bas] ; Michel Bertrand [France] ; Toshiharu Ninomiya [Australie] ; Claudio Ceconi [Italie] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Kim Fox [Royaume-Uni] ; Roberto Ferrari [Italie] ; Jacqueline C. M. Witteman [Pays-Bas] ; A. H. Jan Danser [Pays-Bas] ; Maarten L. Simoons [Pays-Bas] ; Moniek P. M. De Maat [Pays-Bas] | Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease |
002461 (2010) |
Hisatomi Arima [Australie] ; Christophe Tzourio [France] ; Craig Anderson [Australie] ; Mark Woodward [États-Unis] ; Marie-Germaine Bousser [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial |
002768 (2009) |
Jasper J. Brugts [Pays-Bas] ; Toshiharu Ninomiya [Australie] ; Eric Boersma [Pays-Bas] ; Willem J. Remme [Pays-Bas] ; Michel Bertrand [France] ; Roberto Ferrari [Italie] ; Kim Fox [Royaume-Uni] ; Stephen Macmahon [Australie] ; John Chalmers [Australie] ; Maarten L. Simoons [Pays-Bas] | The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials |
003B76 (2006) |
Robyn G. Langham [Australie] ; Daniel J. Cordonnier [France] ; Darken J. Kelly [Australie] ; Nicole Pinel [France] ; Renae M. Gow [Australie] ; Phillipe Zaoui [France] ; YUAN ZHANG [Australie] ; Richard E. Gilbert [Australie, Canada] | Transforming growth factor-β in human diabetic nephropathy : Effects of ACE inhibition |
003F04 (2006) |
Hisatomi Arima [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Craig Anderson [Australie] ; Anthony Rodgers [Nouvelle-Zélande] ; Stephen Davis [Australie] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] | Lower target blood pressures are safe and effective for the prevention of recurrent stroke : the PROGRESS trial |
004640 (2005) |
Carole Dufouil [France] ; John Chalmers [Australie] ; Oguzhan Coskun [France] ; Véronique Besancon [France] ; Marie-Germaine Bousser [France] ; Pierre Guillon [France] ; Stephen Macmahon [Australie] ; Bernard Mazoyer [France] ; Bruce Neal [Australie] ; Mark Woodward [Australie] ; Nathalie Tzourio-Mazoyer [France] ; Christophe Tzourio [France, Australie] | Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke : The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) magnetic resonance imaging substudy |
004867 (2004) |
Jean-Michel Mallion [France] ; Bernard Chamontin [France] ; Roland Asmar [France] ; Peter Wilhelmus De Leeuw [Pays-Bas] ; Eoin O'Brien [Irlande (pays)] ; Daniel Duprez [Belgique, États-Unis] ; Michael F. O'Rourke [Australie] ; Karl-Heinz Rahn [Allemagne] ; Ramon Romero [Espagne] ; Edouard Battegay [Suisse] ; Gerhart Hitzenberger [Autriche] ; Michel E. Safar [France] | Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: The REASON study |
004947 (2004) |
Nicola De Luca [Italie] ; Roland G. Asmar [France] ; Gérard M. London [France] ; Michael F. O'Rourke [Australie] ; Michel E. Safare [France] | Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects |
004966 (2004) |
Nicola De Luca [Italie] ; Jean-Michel Mallion [France] ; Michael F. O'Rourke [Australie] ; Eoin O'Brien [Irlande (pays)] ; Karl-Heinz Rahn [Allemagne] ; Bruno Trimarco [Italie] ; Ramon Romero [Espagne] ; Peter Wilhelmus De Leeuw [Pays-Bas] ; Gerhart Hitzenberger [Autriche] ; Edouard Battegay [Suisse] ; Daniel Duprez [Belgique] ; Peter Sever [Royaume-Uni] ; Michel E. Safar [France] | Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: The REASON echocardiography study |
004A11 (2004) |
Anthony Rodgers [Nouvelle-Zélande] ; Neil Chapman [Australie] ; Mark Woodward [Australie] ; Li-Sheng Liu [République populaire de Chine] ; Sam Colman [Australie] ; Arier Lee [Nouvelle-Zélande] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Francois Gueyffier [France] | Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region. Commentary |
004A68 (2004) |
Gérard M. London [France] ; Roland G. Asmar [France] ; Michaël F. O'Rourke [Australie] ; Michel E. Safar [France] | Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: Comparison with atenolol |
004B73 (2004) |
N. Chapman [Royaume-Uni] ; R. Huxley [Australie] ; C. Anderson [Nouvelle-Zélande] ; M. G. Bousser [France] ; J. Chalmers [Australie] ; S. Colman [Australie] ; S. Davis [Australie] ; G. Donnan [Australie] ; S. Macmahon [Australie] ; B. Neal [Australie] ; C. Warlow [Royaume-Uni] ; M. Woodward [Australie] | Effects of a perindopril-based blood pressure-lowering regimen on the risk of Recurrent Stroke according to Stroke subtype and medical history: The PROGRESS trial |
004D28 (2003) |
John Chalmers [Australie] | Etude ADVANCE: objectifs, protocole et état actuel |
004D83 (2003) |
Stephen B. Harrap [Australie] ; Christophe Tzourio [France] ; Francois Cambien [France] ; Odette Poirier [France] ; Segolene Raoux [France] ; John Chalmers [Australie] ; Neil Chapman [Australie] ; Samuel Colman [Australie] ; Solenn Leguennec [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Takayoshi Ohkubo [Australie] ; Mark Woodward [Australie] | The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition |
005833 (2001) |
Roland G. Asmar [France] ; Gérard M. London [France] ; Michael E. O'Rourke [Australie] ; Michel E. Safar [France] | Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: A comparison with atenolol |
005C26 (2000) |
J. Chalmers [Australie] ; A. Castaigne [France] ; T. Morgan [Australie] ; C. Chastang [France] | Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients |
006065 (1999) |
A. Castaigne [France] ; J. Chalmers [Australie] ; T. Morgan [Australie] ; C. Chastang [France] ; L. Feldmann [France] ; D. Guez [France] | Efficacy and safety of an oral fixed low-dose perindopril 2 mg/indapamide 0.625 mg combination : A randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension |